These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 36115265)
21. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy. Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474 [TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy. Sun Q; Bi H; Wang Z; Li C; Wang X; Xu J; Zhu H; Zhao R; He F; Gai S; Yang P Biomaterials; 2019 Dec; 223():119473. PubMed ID: 31499255 [TBL] [Abstract][Full Text] [Related]
23. Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging. Shu F; Lv D; Song XL; Huang B; Wang C; Yu Y; Zhao SC RSC Adv; 2018 Feb; 8(12):6581-6589. PubMed ID: 35540394 [TBL] [Abstract][Full Text] [Related]
24. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer. Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799 [TBL] [Abstract][Full Text] [Related]
25. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells. Fan Q; Zuo J; Tian H; Huang C; Nice EC; Shi Z; Kong Q J Exp Clin Cancer Res; 2022 May; 41(1):162. PubMed ID: 35501823 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of Cancer Chemotherapeutic Efficacy via Bone-Targeted Drug Delivery Carrier in Bone Metastases. Xue X; Yu J; Lu F; Jiang H; Wang X Drug Des Devel Ther; 2021; 15():4455-4468. PubMed ID: 34737552 [TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer. He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315 [TBL] [Abstract][Full Text] [Related]
28. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors. Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582 [TBL] [Abstract][Full Text] [Related]
29. Dual-crosslinked network of polyacrylamide-carboxymethylcellulose hydrogel promotes osteogenic differentiation in vitro. Chen ZY; Zhou RB; Wang RD; Su SL; Zhou F Int J Biol Macromol; 2023 Apr; 234():123788. PubMed ID: 36822291 [TBL] [Abstract][Full Text] [Related]
30. Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer. Bai SB; Cheng Y; Liu DZ; Ji QF; Liu M; Zhang BL; Mei QB; Zhou SY Nanomedicine (Lond); 2020 Apr; 15(9):833-849. PubMed ID: 32163008 [No Abstract] [Full Text] [Related]
31. Zeolitic Imidazolate Framework-8 Encapsulating Risedronate Synergistically Enhances Osteogenic and Antiresorptive Properties for Bone Regeneration. Cheng X; Zhu Z; Liu Y; Xue Y; Gao X; Wang J; Pei X; Wan Q ACS Biomater Sci Eng; 2020 Apr; 6(4):2186-2197. PubMed ID: 33455339 [TBL] [Abstract][Full Text] [Related]
32. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy. Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789 [TBL] [Abstract][Full Text] [Related]
33. Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer. Huang Y; Xie D; Gou S; Canup BSB; Zhang G; Dai F; Li C; Xiao B Nanoscale; 2021 Mar; 13(11):5765-5779. PubMed ID: 33704300 [TBL] [Abstract][Full Text] [Related]
34. A bone-targeting drug delivery vehicle of a metal-organic framework conjugate with zoledronate combined with photothermal therapy for tumor inhibition in cancer bone metastasis. Ge T; Weiwei Z; Ge F; Zhu L; Song P; Li W; Gui L; Dong W; Tao Y; Yang K Biomater Sci; 2022 Mar; 10(7):1831-1843. PubMed ID: 35253030 [TBL] [Abstract][Full Text] [Related]
35. Zeolitic Imidazolate Frameworks Serve as an Interface Layer for Designing Bifunctional Bone Scaffolds with Antibacterial and Osteogenic Performance. Huang J; Cheng C; Yang Y; Zan J; Shuai C Nanomaterials (Basel); 2023 Oct; 13(21):. PubMed ID: 37947674 [TBL] [Abstract][Full Text] [Related]
36. Hierarchically Released Liquid Metal Nanoparticles for Mild Photothermal Therapy/Chemotherapy of Breast Cancer Bone Metastases via Remodeling Tumor Stromal Microenvironment. Shen Y; Zou Y; Bie B; Lv Y Adv Healthc Mater; 2023 Oct; 12(27):e2301080. PubMed ID: 37436138 [TBL] [Abstract][Full Text] [Related]
37. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543 [TBL] [Abstract][Full Text] [Related]
38. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer. Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182 [TBL] [Abstract][Full Text] [Related]
39. Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497 [TBL] [Abstract][Full Text] [Related]